Yosuke Kitagawa

9PUBLICATIONS

51CO-AUTHORS

Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Medical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 27, 2026

Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.

|Mar 30, 2026

Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cells.

Yosuke Kitagawa, Logan D Muzyka, Ami Kobayashi

|Jul 11, 2025

Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy.

Miyu Kikuchi, Hirokazu Takami, Yukari Kobayashi

|Jul 11, 2024

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula

|May 08, 2024

CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition.

Ali M Nasser, Lisa Melamed, Ethan A Wetzel

|Mar 13, 2024

Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma.

Ami Kobayashi, Yosuke Kitagawa, Ali Nasser

Pageof 2

Frequent Collaborators

Hiroaki Wakimoto

Daniel P Cahill

Ami Kobayashi

Takahide Nejo

Taijun Hana

Hirokazu Takami

Tsukasa Koike

Adam Sheriff

Akitake Mukasa

Masashi Nomura

Frequent Collaborators

Hiroaki Wakimoto

Daniel P Cahill

Ami Kobayashi

Takahide Nejo